How Do I Find a CAH Specialist for Long-Term Care?
At a Glance
For simple virilizing congenital adrenal hyperplasia (CAH), choose an endocrinologist who follows current guidelines, prepares you for adrenal emergencies, and balances hormone tests with growth, blood pressure, bone, fertility, and metabolic health.
Finding an endocrinologist with deep experience in treating classic Congenital Adrenal Hyperplasia (CAH)—specifically the 21-hydroxylase deficiency simple virilizing form—is critical for your long-term health. Because CAH is a rare and lifelong condition, you need a care team that understands its complexities. However, finding the right fit can feel overwhelming. This guide provides a checklist of what to look for, prioritizing both immediate safety and long-term quality of life.
Essential Safety and Care Criteria
When evaluating a potential endocrinologist, prioritize these core elements of care:
- Adherence to Current Guidelines: The 2018 Endocrine Society clinical practice guideline is the recognized benchmark for CAH care [1]. A knowledgeable specialist should base their treatment plans on these or subsequent evidence-based guidelines, focusing on overall well-being and individualized needs [1].
- Understanding the Simple Virilizing Form: CAH is not a one-size-fits-all condition. While classic salt-wasting CAH involves a severe lack of both cortisol and aldosterone (a hormone that helps the body retain salt), patients with the simple virilizing form often produce enough aldosterone [2]. Therefore, you may not need a mineralocorticoid replacement like fludrocortisone [3]. An experienced specialist will base this decision on your blood pressure, electrolytes, and renin (an enzyme that regulates blood pressure) levels, tailoring treatment specifically to the simple virilizing form [2]. Never start, stop, or change your medication without your doctor’s explicit guidance.
- Rigorous Emergency Preparedness: A life-threatening adrenal crisis can occur if your body cannot produce enough cortisol during severe physical stress [4]. While minor injuries do not require intervention, major trauma, surgery, or serious illnesses (especially those involving high fever, vomiting, or an inability to keep oral medication down) require immediate stress-dosing (taking extra glucocorticoid medication) [4]. Inadequate stress-dosing has been linked to severe childhood complications and mortality, even in the simple virilizing form [5]. Your specialist should provide:
- A written, individualized sick-day plan detailing exactly when and how to increase oral medication.
- Prescriptions and training for emergency injectable hydrocortisone.
- Guidance on wearing medical-alert identification stating you have adrenal insufficiency.
- Balancing Labs with Clinical Health: An experienced specialist will never treat a laboratory number in isolation. Proper management requires balancing hormone lab results with regular physical assessments [2]. For children, this means monitoring growth velocity, bone maturation, and pubertal development [6]. For adults, this means tracking blood pressure, fertility, bone density, and metabolic health [7][8]. Your doctor should evaluate how you feel and how you are developing alongside your hormone levels to avoid the risks of overtreatment, such as drug-induced Cushing’s syndrome (a condition caused by prolonged exposure to high cortisol levels) [9][6].
Highly Desirable (But Not Strictly Essential) Resources
While the elements above are mandatory for safe care, the following are highly beneficial. If a local endocrinologist lacks these specific resources, they can still provide excellent care, especially if they are willing to collaborate with a specialized center.
- Affiliation with a Specialized Center: Routine follow-up at a multidisciplinary CAH Center of Excellence or specialized clinic is recommended to manage long-term health needs, smoothly transition from pediatric to adult care, and coordinate reproductive or mental health support [10][8]. If travel is difficult, a knowledgeable local endocrinologist who communicates with a specialized center via telehealth or formal consultation is a highly practical and safe alternative.
- Use of Advanced LC-MS/MS Lab Testing: Accurate monitoring of hormones like 17-hydroxyprogesterone (17-OHP) and androstenedione is crucial. Standard lab tests (immunoassays) can sometimes overestimate these levels, potentially leading a doctor to prescribe too much medication [11]. Advanced testing using LC-MS/MS (Liquid chromatography-tandem mass spectrometry) provides a highly specific hormone profile and is often preferred [12][11]. However, if LC-MS/MS is unavailable in your area, a validated immunoassay is perfectly acceptable. The specialist just needs to use consistent lab practices, check labs at the same time relative to your medication doses, and interpret the results in the context of your physical health rather than trying to force 17-OHP into a strictly “normal” range [13][14].
Common questions in this guide
What experience should I look for in a CAH endocrinologist?
How should a CAH specialist prepare me for an adrenal crisis?
Will everyone with simple virilizing CAH need fludrocortisone?
Do I need to travel to a specialized CAH center?
Are LC-MS/MS hormone tests necessary for CAH monitoring?
Related questions
Show more
Get notified when new evidence is published on Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, simple virilizing form.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (14)
- 1
Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline.
Speiser PW, Arlt W, Auchus RJ, et al.
The Journal of clinical endocrinology and metabolism 2018; (103(11)):4043-4088 doi:10.1210/jc.2018-01865.
PMID: 30272171 - 2
Treatment and Follow-up of Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency in Childhood and Adolescence
Peltek Kendirci HN, Ünal E, Dündar İ, et al.
Journal of clinical research in pediatric endocrinology 2025; (17(Suppl 1)):12-22 doi:10.4274/jcrpe.galenos.2024.2024-6-26-S.
PMID: 39713876 - 3
Severe Hyperandrogenism in 46,XX Congenital Adrenal Hyperplasia: Molecular Physiopathology, Late Diagnoses, and Personalized Management.
Cera G, Corsello A, Novizio R, et al.
International journal of molecular sciences 2024; (25(21)) doi:10.3390/ijms252111779.
PMID: 39519330 - 4
Congenital Adrenal Hyperplasia.
Fraga NR, Minaeian N, Kim MS
Pediatrics in review 2024; (45(2)):74-84 doi:10.1542/pir.2022-005617.
PMID: 38296783 - 5
Mortality in children with classic congenital adrenal hyperplasia and 21-hydroxylase deficiency (CAH) in Germany.
Dörr HG, Wollmann HA, Hauffa BP, et al.
BMC endocrine disorders 2018; (18(1)):37 doi:10.1186/s12902-018-0263-1.
PMID: 29884168 - 6
Congenital Adrenal Hyperplasia in Children: A Pilot Study of Steroid Hormones Expressed as Sex- and Age-Related Standard Deviation Scores.
Clausen CS, Ljubicic ML, Main KM, et al.
Hormone research in paediatrics 2020; (93(4)):226-238 doi:10.1159/000509079.
PMID: 33017824 - 7
Treatment patterns and unmet needs in adults with classic congenital adrenal hyperplasia: A modified Delphi consensus study.
Auchus RJ, Courtillot C, Dobs A, et al.
Frontiers in endocrinology 2022; (13()):1005963 doi:10.3389/fendo.2022.1005963.
PMID: 36465641 - 8
Challenges in Adolescent and Adult Males With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency.
Claahsen-van der Grinten HL, Adriaansen BPH, Falhammar H
The Journal of clinical endocrinology and metabolism 2025; (110(Supplement_1)):S25-S36 doi:10.1210/clinem/dgae718.
PMID: 39836620 - 9
[A promising approach for therapy control in congenital adrenal hyperplasia. Problems of Endocrinology].
Tiulpakov MA, Nagaeva EV, Kalinchenko NY, Bezlepkina OB
Problemy endokrinologii 2024; (69(6)):102-108 doi:10.14341/probl13328.
PMID: 38311999 - 10
[Long-term morbidity in congenital adrenal hyperplasia].
Tschaidse L, Quitter F, Hübner A, Reisch N
Der Internist 2022; (63(1)):43-50 doi:10.1007/s00108-021-01223-6.
PMID: 34978615 - 11
Assay of steroids by liquid chromatography-tandem mass spectrometry in monitoring 21-hydroxylase deficiency.
Dahl SR, Nermoen I, Brønstad I, et al.
Endocrine connections 2018; (7(12)):1542-1550.
PMID: 30530876 - 12
A Liquid Chromatography/Tandem Mass Spectometry Profile of 16 Serum Steroids, Including 21-Deoxycortisol and 21-Deoxycorticosterone, for Management of Congenital Adrenal Hyperplasia.
Fiet J, Le Bouc Y, Guéchot J, et al.
Journal of the Endocrine Society 2017; (1(3)):186-201 doi:10.1210/js.2016-1048.
PMID: 29264476 - 13
Steroid profiling in congenital adrenal hyperplasia: comparing immunoassays and LC-MS/MS accuracy.
Taba-Tabai S, Ozsu E, Cetin SK, et al.
Journal of pediatric endocrinology & metabolism : JPEM 2026; (39(8)):792-802 doi:10.1515/jpem-2025-0538.
PMID: 42380965 - 14
Measurement of twenty-one serum steroid profiles by UPLC-MS/MS for the diagnosis and monitoring of congenital adrenal hyperplasia.
Lee JH, Lee K, Jun SH, et al.
Journal of mass spectrometry and advances in the clinical lab 2025; (38()):10-17 doi:10.1016/j.jmsacl.2025.10.003.
PMID: 41143128
This page is for informational purposes and does not replace medical advice. An endocrinologist familiar with classic CAH should tailor medications, stress-dosing, emergency planning, and monitoring to your needs.